Neuropharmacological and behavioral evaluation of prostaglandin E2 and 11-thiol-11-desoxy prostaglandin E2 in the mouse and rat

scientific article (publication date: 31 May 1978)

Neuropharmacological and behavioral evaluation of prostaglandin E2 and 11-thiol-11-desoxy prostaglandin E2 in the mouse and rat is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1005421087
P356DOI10.1007/BF00426754
P953full work available at URLhttp://link.springer.com/article/10.1007/BF00426754/fulltext.html
http://link.springer.com/content/pdf/10.1007/BF00426754
http://link.springer.com/content/pdf/10.1007/BF00426754.pdf
P698PubMed publication ID97712

P2093author name stringJ. L. Bloss
G. H. Singer
P2860cites workBritish Journal of PharmacologyQ919631
Actions of prostaglandins E1, E2, and F2-alpha on brain stem neuronesQ34794730
ACTIONS OF PROSTAGLANDINS E1, E2 AND E3 ON THE CENTRAL NERVOUS SYSTEMQ35227533
Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effectsQ39874380
Prostaglandins and the central nervous systemQ39899363
The interaction of neuroleptic and muscarinic agents with central dopaminergic systemsQ39999711
Functional role of the nigro-neostriatal dopamine neuronsQ42442278
Prostaglandin-induced neurotransmission failure in the field-stimulated, isolated vas deferensQ46578631
Correlation between catalepsy and dopamine decrease in the rat striatum induced by neurolepticsQ48358515
Neuroleptics: relation between cataleptic and anti-turning actions, and role of the cholinergic systemQ48504302
Antipsychotic drugs and catecholamine synapsesQ48607863
Activation of the pathway from locus coeruleus to rat cerebellar Purkinje neurons: pharmacological evidence of noradrenergic central inhibition.Q48679149
Effect of prostaglandin E 2 on central and peripheral catecholamine neuronsQ48679704
Studies on norepinephrine-containing afferents to Purkinje cells of rat cerebellum. 3. Evidence for mediation of norepinephrine effects by cyclic 3',5'-adenosine monophosphateQ48847260
Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviourQ48873180
DIFFERENCES IN THE EFFECTS OF PROSTAGLANDIN F2-ALPHA, A CONSTITUENT OF CEREBRAL TISSUE, AND PROSTAGLANDIN E1 ON CONSCIOUS CATS AND CHICKS.Q51252740
The effect of prostaglandin E 2 on conditioned avoidance response performance in ratsQ52329767
EFFECTS OF DRUGS ON AVOIDANCE AND ESCAPE BEHAVIORQ52352187
Effects of clozapine, thioridazine, perlapine and haloperidol on the metabolism of the biogenic amines in the brain of the ratQ66851900
Detection of the neuroleptic properties of clozapine, sulpiride and thioridazineQ67300751
Studies on the effect of prostaglandins E1 and E2 on the sympathetic neuromuscular transmission in some animal tissuesQ68625603
On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activityQ69336254
Modulating Effect of Prostaglandin E2on Noradrenaline Release from the Isolated Cat SpleenQ72400895
A note on a simple apparatus for detecting neurological deficit in rats and miceQ74784538
A test for tranquillizing drugsQ77055968
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectpharmacologyQ128406
prostaglandin E2Q416554
P304page(s)295-302
P577publication date1978-05-31
P1433published inPsychopharmacologyQ1422802
P1476titleNeuropharmacological and behavioral evaluation of prostaglandin E2 and 11-thiol-11-desoxy prostaglandin E2 in the mouse and rat
P478volume57